Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts (TMCI) reported Total Non-Current Liabilities of $103.9 million for Q1 2026, up 3.5% on a YoY basis from $100.4 million in Q1 2025, and up 3.65% quarter-over-quarter from $100.2 million in Q4 2025.
Treace Medical Concepts (TMCI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported Total Non-Current Liabilities for 7 years, with the latest figure at $103.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 3.5% year-over-year to $103.9 million; the trailing twelve-month figure through Mar 2026 stood at $103.9 million (up 3.5% YoY), and the FY2025 full-year result was $100.2 million, down 3.75% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $103.9 million, up from $100.2 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $116.2 million in Q1 2024, with the low at $59.6 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $100.6 million across 5 years, with a median of $102.5 million in 2023.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 135.35% — and 2025, when it dropped 13.62%.
- Treace Medical Concepts' Total Non-Current Liabilities stood at $98.5 million in 2022, then increased by 15.66% to $113.9 million in 2023, then declined by 8.61% to $104.1 million in 2024, then declined by 3.75% to $100.2 million in 2025, then increased by 3.65% to $103.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $103.9 million (Q1 2026), $100.2 million (Q4 2025), and $107.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn | 103.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.86 Mn |
| Dec 31, 2025 | 100.20 Mn |
| Sep 30, 2025 | 107.37 Mn |
| Jun 30, 2025 | 108.67 Mn |
| Mar 31, 2025 | 100.35 Mn |
| Dec 31, 2024 | 104.11 Mn |
| Sep 30, 2024 | 107.98 Mn |
| Jun 30, 2024 | 113.91 Mn |
| Mar 31, 2024 | 116.18 Mn |
| Dec 31, 2023 | 113.92 Mn |
| Sep 30, 2023 | 102.46 Mn |
| Jun 30, 2023 | 99.65 Mn |
| Mar 31, 2023 | 91.53 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 94.24 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 59.61 Mn |
| Dec 31, 2021 | 47.58 Mn |
| Sep 30, 2021 | 40.04 Mn |
| Jun 30, 2021 | 39.19 Mn |